Tudor Investment Corp
TPTX

Tudor Investment Corp’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Tudor Investment Corp’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,230
Closed -$2.42M – 2853
2022
Q2 		$2.42M Buy
+32,230
New +$1.43M 0.06% 422
2021
Q2 		– Sell
-12,107
Closed -$1.15M – 2105
2021
Q1 		$1.15M Buy
12,107
+2,935
+32% +$349K 0.02% 774
2020
Q4 		$1.12M Buy
+9,172
New +$1M 0.03% 652

Tudor Investment Corp's TPTX Position: Q3 2022 in Review

Tudor Investment Corp sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 32,230 shares — an estimated $2.42M sold.

Tudor Investment Corp first reported a position in TPTX in Q4 2020 and held it in 3 quarters. The position peaked at $2.42M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Tudor Investment Corp reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 32,230 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.42M.
  • Tudor Investment Corp first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Tudor Investment Corp's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.42M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.